Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Prochymal is a stem cell therapy made by Osiris Therapeutics. It is the first stem cell therapy approved by Canada. It is also the first therapy approved by Canada for acute graft-vs-host disease (GvHD). Also known as remestemcel-L, Prochymal was sold to Australia-based Mesoblast in 2013 at which time its brand name was changed to Ryoncil.
Approvals and indications & Overview
Explore the main themes, entities and connections around Prochymal. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
therapy also stem cell approved canada acute gvhd first mscs derived marrow doses trials trial remestemcel-l ryoncil clinical mesoblast may
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Prochymal | is a | stem cell therapy made by Osiris Therapeutics | 0.90 | text |
| Prochymal | related to Approvals and indications | In May | 0.60 | section |
| Prochymal | related to Approvals and indications | Health Canada | 0.60 | section |
| Prochymal | related to Approvals and indications | GvHD | 0.60 | section |
| Prochymal | related to Approvals and indications | Separately | 0.60 | section |
| Prochymal | related to Approvals and indications | Ryoncil | 0.60 | section |
| Prochymal | related to Approvals and indications | COVID-19 | 0.60 | section |
| Prochymal | related to Approvals and indications | Acute Respiratory Distress Syndrome | 0.60 | section |
| Prochymal | related to Approvals and indications | FDA | 0.60 | section |
| Prochymal | related to Approvals and indications | Phase | 0.60 | section |
| Prochymal | related to Approvals and indications | That | 0.60 | section |
| Prochymal | related to Approvals and indications | May | 0.60 | section |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.